Company Overview of ProFibrix, BV.
ProFibrix, BV. develops and markets products for hemostasis and regenerative medicine markets. It offers Fibrocaps, a dry powder topical fibrin sealant based on a mixture of fibrinogen and thrombin, which helps to stop bleeding during surgery and after trauma injury. The company offers its products based on human fibrinogen, a natural blood protein for blood clotting and tissue healing. ProFibrix, BV. was founded in 2004 and is based in Leiden, the Netherlands with a subsidiary and office in Seattle, Washington. It has a manufacturing site in the United Kingdom. As of August 5, 2013, ProFibrix, BV. operates as a subsidiary of The Medicines Company.
Leiden, 2333 CR
Founded in 2004
31 88 730 8301
31 88 730 8383
Key Executives for ProFibrix, BV.
ProFibrix, BV. Key Developments
Similar Private Companies By Industry
|Mart Microbiology B.V.||Europe|
|MICREOS Food Safety BV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ProFibrix, BV., please visit www.profibrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.